Home LiteratureArticle Details
PMID: 6776034 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Killing of the S and Re forms of Salmonella minnesota via the classical pathway of complement activation in guinea-pig and human sera.

Immunology ·Vol. 40 ·No. 4 ·1980-08-00 ·Pages 547-56

Clas F, Loos M

Abstract

The S (wildtype) and Re form (heptose-deficient, core-defective mutant) of Salmonella minnesota were killed by treatment with normal guinea-pig serum (GPS). Using C4-deficient GPS and serum containing 0.02 M ethyleneglycol-bis-(beta-aminoethylether)-tetraacetic acid and 0.02 M MgCl2 (EGTA-Mg2+) a reduced killing rate was observed. In normal GPS diluted 1:10 containing 0.02 M EGTA-Mg2+ or in C4-deficient GPS diluted 1:10 no killing occurred, whereas the same serum dilution without EGTA-Mg2+ showed a strong bactericidal effect indicating a dependency upon C4 and Ca2+ ions. Furthermore, in contrast to normal human serum (NHS) no killing occurred in a selective complete C1q-deficient human serum. The bactericidal effect, however, could be restored by addition of highly purified C1q; this is a further indication for a dependency upon the classical pathway of C activation. The C-dependent bactericidal activity was totally abolished when phosphate buffer was used, partially reduced in the presence of veronal-buffered saline (VBS), and not affected by tris-(hydroxymethyl)-aminomethane(Tris) or thioglycollate-buffered system EGTA-Mg2+ alone slightly reduced the growth rate of the bacteria whereas disodium ethylene diaminetetraacetate (EDTA) had a bacteriostatic effect on the S-form. The inhibition of the growth of the Re-form by EDTA was amplified by the addition of serum. Pre-incubation of bacteria with serum for absorption of antibodies did not increase the killing rate of such pre-treated bacteria excluding an antibody-mediated bactericidal reaction. Furthermore, pre-treatment of the bacteria with GPS at 0 degrees reduced the serum sensitivity of both types of bacteria.

MeSH Terms
Animals Blood Bactericidal Activity/drug effects Buffers Complement Activation Complement C1/deficiency Complement C4/deficiency Complement Pathway, Classical Edetic Acid/pharmacology Egtazic Acid/pharmacology Guinea Pigs Humans Mutation Salmonella/drug effects,immunology
Chemicals
Buffers Complement C1 Complement C4 Egtazic Acid Edetic Acid
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Clas F
Loos M
References (17)
17 references, click to expand
  1. Sensitivity of rough gram-negative bacteria to the bactericidal action of serum.
    J Bacteriol. 1968 May;95(5):1647-50 PMID: 5650074
  2. Calcium requirements for complement dependent hemolytic reactions.
    J Immunol. 1968 Oct;101(4):664-8 PMID: 5681648
  3. Interactions of the complement system with endotoxic lipopolysaccharide: consumption of each of the six terminal complement components.
    J Exp Med. 1968 Nov 1;128(5):1049-57 PMID: 4176223
  4. Studies on the presence and role of tryptophan in pig heart mitochondrial malate dehydrogenase.
    J Biol Chem. 1968 Dec 10;243(23):6284-90 PMID: 5723469
  5. Sensitization of complement resistant bacterial strains.
    Nature. 1969 Mar 29;221(5187):1259-61 PMID: 4975337
  6. An alternate complement pathway: C-3 cleaving activity, not due to C4,2a, on endotoxic lipopolysaccharide after treatment with guinea pig serum; relation to properdin.
    Proc Natl Acad Sci U S A. 1971 Jun;68(6):1351-4 PMID: 5288385
  7. Analysis of bypass activation of C3 by endotoxic LPS and loss of this potency.
    Immunology. 1973 Apr;24(4):721-33 PMID: 4122408
  8. Interaction of the first (C1), the second (C2) and the fourth (C4) component of complement with different preparations of bacterial lipopolysaccharides and with lipid A.
    J Immunol. 1974 Mar;112(3):935-40 PMID: 4590707
  9. Rabbit C1q: purification, functional and structural studies.
    J Immunol Methods. 1972 Nov;2(1):25-34 PMID: 4139208
  10. Activation of the classical and properdin pathways of complement by bacterial lipopolysaccharides (LPS).
    J Immunol. 1977 Jan;118(1):362-8 PMID: 318670
  11. Interactions between mycoplasma pneumoniae and the first components of complement.
    Infect Immun. 1977 Jan;15(1):7-12 PMID: 832909
  12. Activation of complement by opportunist pathogens and chemotypes of Salmonella minnesota.
    Infect Immun. 1977 Jun;16(3):748-53 PMID: 408268
  13. Binding and activation of the first component of human complement by the lipid A region of lipopolysaccharides.
    J Immunol. 1978 Jun;120(6):1862-8 PMID: 351060
  14. Differences in activation of human and guinea pig complement by retroviruses.
    J Immunol. 1978 Nov;121(5):1748-51 PMID: 213489
  15. Antibody-independent interaction of the first component of complement with Gram-negative bacteria.
    Infect Immun. 1978 Oct;22(1):5-9 PMID: 365750
  16. Clinical and immunological studies in a case of selective complete C1q deficiency.
    Clin Exp Immunol. 1979 Oct;38(1):52-63 PMID: 527255
  17. THE RELATION BETWEEN THE BACTERICIDAL ACTIVITY OF COMPLEMENT AND THE CHARACTER OF THE BACTERIAL SURFACES.
    Folia Microbiol (Praha). 1964 Sep;89:284-98 PMID: 14208479
Article Info
Journal
Immunology
Abbr.
Immunology
ISSN
0019-2805
Published
1980-08-00
Pages
547-56
Language
English
Region
England
NLM ID
0374672
PMCID
PMC1458113
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com